EN
HI
Summary
As of 29 Aug, 2026, Biocon stock price is ₹411.1. During the trading session, the stock has moved between an intraday low of ₹410.00 and an intraday high of ₹418.65. Over the last 52 weeks, Biocon has traded between ₹337.05 and ₹447.15.
The stock has recorded a trading volume of 21,87,557 shares, with a market capitalization of ₹1620907773. Its Average Traded Price (ATP) is ₹412.84, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 74 @ ₹411.10.
Biocon has an upper circuit limit of ₹452.20 and a lower circuit limit of ₹370.00. The total value traded stands at ₹90.31 CR, and the delivery percentage for the day is 46.38%.
The stock is currently traded with a market lot size of 1. Biocon also offers a dividend yield of 0.12%.
Biocon share price chart
Biocon Share Key Metrics
Volume
21.88 L
Market Cap
66635.52 CR
LTQ@LTP
74@411.10
ATP
412.84
Var Margin
14.73 %
Circuit Range
370-452.2
Delivery %
46.38 %
Value
90.31 CR
ASM/GSM
No
Market Lot
1
Biocon Fundamentals
P/E Ratio
137.47
P/B Ratio
2
Div. Yield
0.12
Sector P/E
68.56
Sector P/B
3.39
Sec. Div. Yield
0.51
Biocon Resistance and Support
Pivot 418.33
Resistance
First Resistance
421.66
Second Resistance
424.93
Third Resistance
428.26
Support
First Support
415.06
Second Support
411.73
Third Support
408.46
Biocon Futures & Options
Biocon Option Chain
View Price, OI, Greeks & More...
29SEP26
415.15
-5.10 (1.21%)
27OCT26
417.20
-5.45 (1.29%)
23NOV26
418.90
-4.30 (1.02%)
BIOCON|29SEP26 CE 410.00
13.05
-2.6 (-16.61%)
BIOCON|29SEP26 PE 415.00
9.35
1.85 (24.67%)
Biocon Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 28 2026 | 416.4 | 411.1 | -1.74% | 418.65 | 410 |
| Thu Aug 27 2026 | 415 | 418.39 | 0.21% | 421.6 | 415 |
| Wed Aug 26 2026 | 417.79 | 417.5 | 0.07% | 419.45 | 414.75 |
Biocon Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-10-01 | Redemption (Part) of NCD |
| 2025-08-07 | Quarterly Results |
| 2025-05-08 | Audited Results & Final Dividend |
| 2025-04-23 | Others |
| 2025-04-04 | To consider Fund Raising |
| 2025-01-30 | Quarterly Results & Others |
| 2025-01-27 | Others |
| 2024-10-30 | Quarterly Results |
Biocon News
Biocon Ltd - 532523 - Communication Regarding Remittance Of Final Dividend For The FY 2025-26
Biocon has completed the remittance of the final dividend of Rs.0.50 per equity share for the financial year 2025-26. This dividend was approved by shareholders at the 48th Annual General Meeting held on August 06, 2026, with a record date of July 03, 2026.
Aug 28 2026 20:58:05
Biocon Ltd - 532523 - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Mylan Inc. clarified its full divestment from Biocon, confirming a nil shareholding after selling its entire 5.64% stake on July 14, 2026. This rectifies a typographical error in a previous disclosure.
Aug 26 2026 14:51:42
Read More
Biocon Management
| Name | Position |
|---|---|
| Kiran Mazumdar-Shaw | Chairperson |
| Ravi Rasendra Mazumdar | Non Independent & Non Executive Director |
Biocon Similar Stocks
Mankind Pharma Ltd.
2382.90
-34.60 (1.43%)
Max Healthcare Institute Ltd.
1014.10
5.10 (0.51%)
Aurobindo Pharma Ltd.
1645.30
8.30 (0.51%)
Fortis Healthcare Ltd.
926.75
11.10 (1.21%)
Glenmark Pharmaceuticals Ltd.
2515.00
55.00 (2.24%)
Aster DM Quality Care Ltd.
748.40
-6.40 (0.85%)
Alkem Laboratories Ltd.
5355.00
35.00 (0.66%)
Abbott India Ltd.
26175.00
-175.00 (0.66%)
Anthem Biosciences Ltd.
900.10
-24.50 (2.65%)
Glaxosmithkline Pharmaceuticals Ltd.
3106.40
37.30 (1.22%)
Biocon FAQs
The Buying Price of Biocon share is 411.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Biocon stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Biocon, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Biocon shares is 137.47. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Biocon shares is 2. Useful to assess the stock's value relative to its book value.
To assess Biocon’s valuation compare Sector P/E, P/B which are 68.56 & 3.39 with sector averages, along with growth rates and financial metrics.
The Market Cap of Biocon is 66635.52 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Biocon share price is 447.15 & 337.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Biocon belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
